BioSpace News Archive

Humans and chimpanzees differ in only one percent of their DNA. Human accelerated regions (HARs) are parts of the genome with an unexpected amount of these differences.

NurExone Biologic Inc. has received a notice of allowance from the United States Patent and Trademark Office for U.S. Patent Application NO. 17/042,441.

Kezar Life Sciences, Inc. announced that the Compensation Committee of the company’s Board of Directors granted two employees nonqualified stock options to purchase 65,000 shares of its common stock with an exercise price of $6.84 per share, which is equal to the closing price of Kezar’s common stock on January 6, 2023, the grant date of the awards.

Atara Biotherapeutics, Inc. reported the grant of 66,800 restricted stock units of Atara’s common stock to six newly hired employees and stock options to purchase an aggregate of 40,000 shares of Atara’s common stock to one such newly hired employee.

Centene Corporation issued a reminder that it will release its 2022 fourth quarter and full year financial results at approximately 6 a.m. on Tuesday, February 7, 2023, and will host a conference call afterwards at approximately 8:30 a.m. to review the results.

Seno Medical has entered into an exclusive distributor agreement with Genetik, Inc., to market, sell and service the company’s groundbreaking Imagio® Opto-Acoustic/Ultrasound Breast Imaging System.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Aesther Healthcare Acquisition Corp and Ocean Biomedical, Inc. announced that AEHA has filed with the U.S. Securities and Exchange Commission a definitive proxy statement in connection with its proposed business combination with Ocean and with respect to the special meeting of Aesther’s stockholders scheduled to be held on February 3, 2023.

A groundbreaking research study by a team that included scientists from Benson Hill, Inc., has been published this month in Nature, the world’s leading multidisciplinary journal, highlighting a new mechanism for Clustered Regularly Interspaced Short Palindromic Repeats technology.

Biomerica, Inc., a global provider of advanced medical products, reported its second quarter fiscal 2023 financial results for the period ended November 30, 2022.